pneumonia
major
caus
death
children
throughout
develop
world
especi
children
age
year
death
attribut
acut
respiratori
infect
caus
pneumonia
bronchiol
data
caus
pneumonia
requir
region
death
due
pneumonia
common
order
inform
casemanag
guidelin
potenti
prevent
strategi
bacteri
conjug
vaccin
inher
difficulti
pneumonia
aetiolog
studi
low
yield
blood
cultur
lung
aspir
cultur
provid
higher
diagnost
yield
specif
caus
pathogen
blood
cultur
lung
aspir
safe
provid
reliabl
diagnost
inform
lung
aspir
studi
contribut
significantli
understand
bacteri
aetiolog
pneumonia
data
studi
provid
import
evid
base
casemanag
strategi
recommend
world
health
organ
howev
case
blood
cultur
yield
lung
aspir
cultur
like
affect
prior
antibiot
usag
especi
fastidi
organ
streptococcu
pneumonia
pcr
lung
aspir
fluid
increas
yield
especi
patient
receiv
antibiot
contribut
virus
aetiolog
pneumonia
uncertain
studi
utilis
nasopharnyg
aspir
therefor
difficult
impli
causat
viru
detect
nasopharynx
may
simpli
reflect
colonis
south
african
children
viral
pathogen
identifi
less
frequent
bacteri
pathogen
hivinfect
children
hivinfect
children
sever
viral
lower
respiratori
tract
infect
lrti
higher
mortal
hivuninfect
children
children
year
age
lrti
pathogen
identifi
predominantli
rsv
influenza
ab
parainfluenza
adenoviru
polymicrobi
diseas
identifi
major
caus
treatment
failur
children
year
age
south
africa
perform
lung
aspir
select
group
malawian
children
part
larger
descript
studi
examin
cytokin
profil
genet
determin
invas
pneumococc
diseas
report
use
pcr
detect
streptococcu
pneumonia
haemophilu
influenza
type
b
hib
mycoplasma
pneumonia
chlamydia
pneumonia
pneumocysti
jirovecii
nine
respiratori
virus
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
influenza
b
parainfuenza
viru
coronaviru
rhinoviru
adenoviru
human
bocaviru
hbov
lung
aspir
specimen
compar
diagnost
yield
bacteria
pcr
appli
lung
aspir
bacteriolog
cultur
blood
lung
aspir
fluid
show
pcr
lung
aspir
fluid
increas
diagnost
yield
studi
period
screen
children
clinic
diagnosi
pneumonia
chest
radiograph
lobar
focal
segment
consolid
recruit
children
april
octob
median
age
year
interquartil
rang
iqr
year
total
male
hivinfect
die
characterist
children
radiolog
confirm
pneumonia
shown
tabl
case
immunis
complet
record
report
complet
dose
primari
immunis
includ
hib
case
present
throughout
year
peak
pneumonia
case
occur
august
novemb
hot
dri
season
pathogen
bacteri
viral
pneumocysti
identifi
children
either
singli
coinfect
sampl
patient
posit
cultur
blood
cultur
lung
aspir
cultur
aetiolog
agent
list
tabl
commonest
bacteri
organ
spneumonia
follow
h
influenza
b
commonest
viru
identifi
adenoviru
follow
human
bocaviru
hbov
either
singl
coinfect
total
children
hbov
age
year
infant
hbov
infect
month
old
coinfect
cmv
also
hivinfect
two
children
viral
coinfect
hivinfect
bacterialvir
coinfect
occur
children
hivinfect
commonest
pneumoniaeadenoviru
case
four
six
hib
case
hivinfect
pjirovecii
identifi
infant
hivinfect
less
month
age
coinfect
hib
adenoviru
c
pneumonia
respect
die
four
children
hib
pneumonia
fulli
immunis
one
receiv
one
dose
one
record
immunis
statu
blood
cultur
posit
children
spneumonia
salmonella
typhimurium
lung
aspir
cultur
posit
children
one
spneumonia
blood
cultur
neg
one
typhimurium
blood
cultur
posit
total
children
bacteraem
blood
cultur
blood
pcr
pneumococcu
hib
report
prior
antibiot
usag
two
case
lung
aspir
cultur
posit
one
receiv
antimalari
sulphadoxinepyrimethamin
prior
admiss
prior
antibiot
report
bacteria
identifi
pcr
without
bacteria
identifi
pcr
p
chisquar
test
children
confirm
bacteri
pneumonia
either
singli
coinfect
significantli
less
like
sign
grunt
requir
oxygen
therapi
children
without
confirm
bacteri
pneumonia
tabl
children
posit
lung
aspir
blood
pcr
pneumococc
dna
pneumococc
bacteri
load
avail
lung
aspir
bacteri
load
n
rang
copiesml
median
iqr
copiesml
blood
bacteri
load
n
rang
copiesml
median
iqr
copiesml
blood
lung
aspir
median
bacteri
load
higher
nonsurvivor
survivor
differ
signific
blood
versu
copiesml
lung
aspir
versu
copiesml
respect
lung
aspir
bacteri
load
lower
hivinfect
children
blood
bacteri
load
higher
differ
signific
lung
aspir
versu
copiesml
blood
versu
copiesml
respect
correl
lung
blood
bacteri
load
follow
lung
aspir
two
patient
pneumothorax
side
aspir
one
present
worsen
respiratori
distress
hour
aspir
larg
tension
pneumothorax
diagnos
intercost
chest
drain
insert
child
well
small
crescent
air
pleural
space
detect
postaspir
cxr
requir
manag
six
children
die
hivinfect
three
pcp
identifi
coinfect
three
without
pcp
sever
malnourish
one
age
year
heightforag
z
score
weightforheight
z
score
develop
convuls
hospit
stay
one
age
month
coinfect
hbov
cmv
heightforag
z
score
one
age
year
kwashiorkor
infect
spneumonia
weightforheight
z
score
demonstr
lung
aspir
pcr
significantli
improv
diagnosi
radiolog
pneumonia
identifi
blood
lung
aspir
cultur
identifi
blood
lung
aspir
cultur
lung
aspir
pcr
coinfect
occur
commonli
hivinfect
hivuninfect
children
provid
first
report
hbov
detect
lung
aspir
sampl
children
radiolog
confirm
pneumonia
strength
studi
perform
pcr
improv
diagnosi
viral
bacteri
aetiolog
perform
lung
aspir
cultur
pcr
well
blood
cultur
studi
pneumonia
aetiolog
previous
use
blood
cultur
identifi
bacteri
aetiolog
lung
aspir
perform
select
group
children
pneumonia
therefor
find
necessarili
repres
spectrum
aetiolog
radiolog
pneumonia
popul
select
children
focal
lobar
segment
consolid
meant
case
pcp
like
exclud
probabl
account
lower
overal
case
fatal
rate
studi
report
compar
studi
median
age
group
higher
children
pneumonia
present
queen
elizabeth
central
hospit
pathogen
commonli
occur
infant
rsv
pcp
may
therefor
underrepres
studi
lung
aspir
pcr
design
identifi
small
number
bacteria
identifi
gram
neg
organ
klebsiella
nontyphoid
salmonella
valid
pcr
assay
klebsiella
nontyphoid
salmonella
staphylococcu
aureu
avail
laboratori
find
pcr
much
sensit
cultur
children
lung
aspir
perform
like
reflect
frequent
use
antibiot
prior
present
well
inher
increas
sensit
test
cultur
fact
urin
test
antibiot
activ
may
result
signific
underreport
previou
antibiot
exposur
may
contribut
low
cultur
posit
rate
despit
posit
bacteri
pcr
organ
identifi
sampl
obtain
directli
consolid
lung
like
caus
agent
organ
retriev
sampl
nasopharyng
aspir
even
bronchoalveolar
lavag
risk
contamin
sampl
carriag
isol
nasopharyng
carriag
pneumococcu
common
among
well
infant
region
malawi
limit
rtpcr
compar
cultur
provid
antibiot
suscept
data
serotyp
data
provid
lung
aspir
sampl
use
luminex
technolog
pcr
assay
avail
us
time
studi
report
studi
pneumonia
children
lung
aspir
use
review
publish
seri
pneumothorax
complic
rate
seven
death
report
lung
aspir
mortal
approxim
although
death
thought
directli
attribut
lung
aspir
data
consist
studi
finland
use
lung
aspir
diagnosi
childhood
pneumonia
lung
aspir
disclos
aetiolog
studi
howev
significantli
higher
complic
rate
pneumothorax
develop
children
compar
complic
rate
studi
must
emphas
lung
aspir
recommend
child
suspect
suffer
pcp
increas
risk
pneumothorax
rel
low
number
case
hib
pneumonia
reflect
effect
hib
immunis
primari
immunis
schedul
hbov
associ
clinic
ill
mani
studi
often
occur
coinfect
led
debat
whether
hbov
true
pathogen
innoc
bystand
recent
studi
et
al
suggest
host
immun
system
recognis
hbov
pathogen
elicit
signific
antibodi
respons
hbov
also
associ
pneumonia
requir
hospit
young
children
thailand
studi
first
studi
report
hbov
detect
lung
aspir
sampl
children
radiolog
pneumonia
strongli
suggest
infect
aros
lower
airway
oppos
mere
colonis
nasopharynx
recent
studi
finland
found
high
concentr
hbov
induc
sputum
also
suggest
viru
may
origin
lower
airway
recent
studi
kenya
infant
children
present
sever
pneumonia
one
respiratori
virus
detect
nasal
wash
sampl
pcr
studi
children
bacteraem
compar
studi
anoth
recent
studi
mozambiqu
nasopharyng
aspir
sampl
children
year
sever
pneumonia
least
one
respiratori
viru
detect
pcr
viral
infect
preval
hivinfect
children
inhospit
mortal
highest
children
invas
bacteri
coinfect
hiv
infect
given
children
report
studi
fulfil
criteria
sever
pneumonia
would
therefor
receiv
parenter
antibiot
urgent
need
reliabl
afford
point
care
diagnost
help
differenti
bacteri
viral
aetiolog
attempt
promot
judici
antibiot
prescrib
previous
report
perform
five
diagnost
biomark
predict
seriou
bacteri
infect
sbi
african
children
current
studi
report
median
creactiv
protein
procalcitonin
level
admiss
significantli
higher
children
confirm
bacteri
pneumonia
children
pneumonia
without
bacteri
confirm
degre
overlap
data
shown
larger
studi
assess
perform
biomark
sbi
children
present
sever
pneumonia
indic
augment
molecular
diagnost
test
enhanc
diagnosi
bacteri
infect
allow
accur
predict
util
biomark
guid
antibiot
prescrib
shown
lung
aspir
pcr
significantli
increas
diagnost
yield
children
focal
segment
lobar
consolid
keep
recent
studi
develop
world
use
pcr
viru
detect
studi
add
grow
bodi
evid
spneumonia
respiratori
virus
contribut
significantli
aetiolog
childhood
pneumonia
africa
provid
first
report
hbov
lung
aspir
sampl
suggest
pathogen
role
viru
radiolog
confirm
pneumonia
ethic
approv
obtain
colleg
medicin
research
ethic
committe
liverpool
school
tropic
medicin
research
ethic
committe
inform
provid
english
chichewa
written
consent
obtain
particip
prospect
observ
studi
cytokin
profil
genet
determin
invas
pneumococc
diseas
children
present
pneumonia
mening
undertaken
queen
elizabeth
central
hospit
qech
blantyr
april
octob
detail
studi
particip
recruit
procedur
previous
report
children
screen
inclus
present
studi
clinic
diagnosi
pneumonia
radiolog
confirm
pneumonia
focal
segment
lobar
pneumonia
enrol
routin
immunis
period
studi
includ
neonat
bcg
dpthep
b
hib
conjug
vaccin
week
hib
vaccin
introduc
malawi
pneumococc
conjug
vaccin
avail
throughout
studi
period
clinic
data
collect
enrol
studi
follow
written
inform
consent
includ
prior
current
treatment
antibiot
antimalari
chest
radiograph
perform
admiss
children
focal
lobar
segment
consolid
recruit
arteri
oxygen
satur
breath
air
measur
puls
oximetri
monitor
regularli
along
vital
sign
throughout
hospit
stay
nurs
staff
accord
research
ward
protocol
urin
test
antibiot
activ
children
review
studi
clinician
least
twice
per
day
blood
ml
taken
cultur
prior
commenc
antibiot
cultur
use
bactalert
autom
system
biomerieux
franc
isol
identifi
use
standard
diagnost
techniqu
antibiot
suscept
test
use
kirbybau
disk
diffus
method
hiv
test
done
follow
separ
written
inform
consent
pre
posttest
counsel
provid
train
nurs
counsellor
accept
test
hiv
statu
determin
patient
children
month
hiv
statu
assess
use
least
two
follow
test
unigold
triniti
biotech
ireland
serocard
triniti
biotech
wicklow
ireland
determinehiv
abbott
laboratori
illinoi
usa
children
month
discord
antibodi
test
hiv
statu
determin
use
amplicor
dna
roch
diagnost
usa
singl
needl
aspir
consolid
lung
perform
prior
commenc
antibiot
hospit
written
inform
consent
patient
fit
select
criteria
chest
radiograph
immedi
avail
show
area
consolid
adjac
chest
wall
hyperinfl
pneumocysti
pneumonia
pcp
suspect
children
sever
hypoxia
exclud
area
consolid
confirm
auscult
percuss
asept
clean
skin
needl
attach
ml
syring
contain
ml
steril
normal
salin
advanc
area
consolid
needl
remov
whilst
maintain
continu
suction
steril
salin
syring
use
facilit
remov
lung
fluid
debri
syring
needl
chest
radiograph
perform
routin
aspir
within
one
hour
time
indic
air
leak
suspect
paediatr
chest
drain
kit
rang
size
alway
avail
ward
lung
aspir
fluid
cultur
use
bactalert
autom
system
remaind
sampl
store
analysi
bacteri
dna
h
influenza
pneumonia
amplifi
quantifi
use
realtim
pcr
assay
use
capsul
bexa
pneumolysin
pli
gene
target
specif
h
influenza
pneumonia
respect
use
abi
sequenc
detect
system
taqman
shown
improv
noncultur
diagnosi
case
ascertain
realtim
quantit
pcr
cmv
perform
use
abi
sequenc
detect
system
taqman
use
primer
previous
describ
realtim
pcr
pneumocysti
jirovecii
amplifi
section
larg
subunit
mitochondri
rna
qualit
pcr
also
perform
lung
aspir
fluid
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
influenza
ab
parainfuenza
viru
coronaviru
rhinoviru
adenoviru
chlamydia
pneumonia
mycoplasma
pneumonia
human
bocaviru
hbov
briefli
rna
dna
extract
use
commerci
kit
qiagen
basingstok
uk
extract
rna
use
duplex
rtpcr
method
rsv
nucleocapsid
hmpv
matrix
gene
detect
use
primer
previous
describ
multiplex
influenza
rtpcr
perform
identifi
influenza
b
second
multiplex
rtpcr
util
detect
parainfluenza
viru
type
adenoviru
chlamydia
pneumonia
detect
use
previous
publish
protocol
hcov
genom
amplifi
separ
rtpcr
use
previous
publish
primer
hcov
hcov
bocaviru
detect
use
primer
publish
previous
rhinoviru
detect
use
multiplex
method
describ
choi
multiplex
pcr
assay
respiratori
virus
use
group
previou
studi
lung
aspir
fluid
cultur
mycobacterium
tuberculosi
confirm
bacteri
pneumonia
defin
radiolog
evid
pneumonia
focal
segment
lobar
consolid
plu
one
follow
blood
lung
aspir
cultur
posit
lung
aspir
posit
pneumococc
polysaccharid
antigen
hib
antigen
pcr
posit
pneumonia
h
influenza
b
cutoff
valu
copiesml
use
determin
posit
pcr
either
blood
lung
aspir
cutoff
valu
use
base
previou
studi
use
pneumococc
dna
differenti
carriag
diseas
case
control
carrol
ed
unpublish
increas
work
breath
recess
grunt
nasal
flare
use
accessori
muscl
respir
median
level
pneumococc
bacteri
load
compar
two
group
use
mannwhitney
u
test
test
associ
binari
variabl
perform
use
fisher
exact
test
report
p
valu
twotail
signific
level
use
infer
statist
signific
statist
packag
social
scienc
spss
version
illinoi
usa
use
analys
